Shandong Xinhua Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Shandong Xinhua Pharmaceutical has a total shareholder equity of CN¥5.0B and total debt of CN¥1.4B, which brings its debt-to-equity ratio to 28.1%. Its total assets and total liabilities are CN¥8.7B and CN¥3.8B respectively. Shandong Xinhua Pharmaceutical's EBIT is CN¥473.5M making its interest coverage ratio 28.6. It has cash and short-term investments of CN¥996.3M.
Key information
28.1%
Debt to equity ratio
CN¥1.40b
Debt
| Interest coverage ratio | 28.6x |
| Cash | CN¥996.33m |
| Equity | CN¥4.97b |
| Total liabilities | CN¥3.76b |
| Total assets | CN¥8.73b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 719's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥2.6B).
Long Term Liabilities: 719's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 719's net debt to equity ratio (8.1%) is considered satisfactory.
Reducing Debt: 719's debt to equity ratio has reduced from 44.6% to 28.1% over the past 5 years.
Debt Coverage: 719's debt is well covered by operating cash flow (23%).
Interest Coverage: 719's interest payments on its debt are well covered by EBIT (28.6x coverage).